de Visser KE
de Visser KE
Adresse e-mail validée de
TitreCitée parAnnée
Paradoxical roles of the immune system during cancer development
KE De Visser, A Eichten, LM Coussens
Nature reviews cancer 6 (1), 24, 2006
De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent
KE de Visser, LV Korets, LM Coussens
Cancer cell 7 (5), 411-423, 2005
Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy
CH Ries, MA Cannarile, S Hoves, J Benz, K Wartha, V Runza, ...
Cancer cell 25 (6), 846-859, 2014
IL-17-producing gdT cells and neutrophils conspire to promote breast cancer metastasis
SB Coffelt, K Kersten, CW Doornebal, J Weiden, K Vrijland, CS Hau, ...
Nature, 2015
FcRγ activation regulates inflammation-associated squamous carcinogenesis
P Andreu, M Johansson, NI Affara, F Pucci, T Tan, S Junankar, L Korets, ...
Cancer cell 17 (2), 121-134, 2010
Chimeric papillomavirus virus-like particles elicit antitumor immunity against the E7 oncoprotein in an HPV16 tumor model
HL Greenstone, JD Nieland, KE De Visser, MLH De Bruijn, R Kirnbauer, ...
Proceedings of the National Academy of Sciences 95 (4), 1800-1805, 1998
Neutrophils in cancer: neutral no more
SB Coffelt, MD Wellenstein, KE de Visser
Nature Reviews Cancer 16 (7), 431-446, 2016
Selective induction of chemotherapy resistance of mammary tumors in a conditional mouse model for hereditary breast cancer
S Rottenberg, AOH Nygren, M Pajic, FWB van Leeuwen, ...
Proceedings of the National Academy of Sciences 104 (29), 12117-12122, 2007
The inflammatory tumor microenvironment and its impact on cancer development
K de Visser, L Coussens
Infection and Inflammation: Impacts on Oncogenesis 13, 118-137, 2006
Effects of TGF-ß on the immune system: implications for cancer immunotherapy
KE De Visser, WM Kast
Leukemia 13, 1188-1199, 1999
Inflammation, proteases and cancer
LCL van Kempen, KE de Visser, LM Coussens
European journal of cancer 42 (6), 728-734, 2006
A comprehensive analysis of prognostic signatures reveals the high predictive capacity of the proliferation, immune response and RNA splicing modules in breast cancer
F Reyal, MH Van Vliet, NJ Armstrong, HM Horlings, KE de Visser, M Kok, ...
Breast Cancer Research 10 (6), R93, 2008
Developmental stage‐specific contribution of LGR5+ cells to basal and luminal epithelial lineages in the postnatal mammary gland
KE de Visser, M Ciampricotti, E Michalak, D Wei‐Min Tan, EN Speksnijder, ...
The Journal of Pathology, 2012
The interplay between innate and adaptive immunity regulates cancer development
KE De Visser, LM Coussens
Cancer Immunology, Immunotherapy 54 (11), 1143-1152, 2005
Chimeric papillomavirus virus‐like particles induce a murine self‐antigen‐specific protective and therapeutic antitumor immune response
JD Nieland, DM Da Silva, MP Velders, KE de Visser, JT Schiller, M Müller, ...
Journal of cellular biochemistry 73 (2), 145-152, 1999
Genetically engineered mouse models in oncology research and cancer medicine
K Kersten, KE de Visser, MH van Miltenburg, J Jonkers
EMBO molecular medicine 9 (2), 137-153, 2017
Immunological and antitumor effects of IL-23 as a cancer vaccine adjuvant
WW Overwijk, KE de Visser, FH Tirion, LA de Jong, TWH Pols, ...
The Journal of Immunology 176 (9), 5213-5222, 2006
Chemotherapy response of spontaneous mammary tumors is independent of the adaptive immune system
M Ciampricotti, CS Hau, CW Doornebal, J Jonkers, KE de Visser
Nature medicine 18 (3), 344-346, 2012
Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape
MD Wellenstein, KE de Visser
Immunity 48 (3), 399-416, 2018
Cancer: Inflammation lights the way to metastasis
SB Coffelt, KE De Visser
Nature 507 (7490), 48-49, 2014
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20